|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400093521 |
|
最近更新日期: Date of Last Refreshed on: |
2024-12-06 10:55:41 |
|
注册时间: Date of Registration: |
2024-12-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
社区老年人年龄相关性听力损失运动干预方案的开发与评价 |
|
Public title: |
Development and Evaluation of an Exercise Intervention Program for Age-Related Hearing Loss in Community-Dwelling Elderly |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
社区老年人年龄相关性听力损失运动干预方案的开发与评价 |
|
Scientific title: |
Development and Evaluation of an Exercise Intervention Program for Age-Related Hearing Loss in Community-Dwelling Elderly |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李静 |
研究负责人: |
刘均娥 |
|
Applicant: |
Li Jing |
Study leader: |
Li Jun e |
|
申请注册联系人电话: Applicant telephone: |
+86 155 2206 2131 |
研究负责人电话: Study leader's telephone: |
+86 185 0013 6128 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
ljlss1107@163.com |
研究负责人电子邮件: Study leader's E-mail: |
liujune66@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市丰台区右安门外西头条10号首都医科大学 |
研究负责人通讯地址: |
北京市丰台区右安门外西头条10号首都医科大学 |
|
Applicant address: |
Capital Medical University, No. 10, Xitou Tiao, You'anmen Outer, Fengtai District, Beijing, China |
Study leader's address: |
Capital Medical University, No. 10, Xitou Tiao, You'anmen Outer, Fengtai District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
首都医科大学 |
||
|
Applicant's institution: |
Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学 |
||
|
Affiliation of the Leader: |
Capital Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
Z2024SY071 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-11-20 00:00:00 |
||
|
伦理委员会联系人: |
刘芳 |
||
|
Contact Name of the ethic committee: |
Liu Fang |
||
|
伦理委员会联系地址: |
北京市丰台区右安门外西头条10号首都医科大学 |
||
|
Contact Address of the ethic committee: |
Capital Medical University, No. 10, Xitou Tiao, You'anmen Outer, Fengtai District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 83911736 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
首都医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Capital Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市丰台区右安门外西头条10号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 10, Xitou Tiao, You'anmen Outer, Fengtai District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
北京市卫生健康委员会 |
||||||||||||||||||||||
|
Source(s) of funding: |
Beijing Municipal Health Commission |
||||||||||||||||||||||
|
Target disease: |
Age-related hearing loss |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
通过随机对照研究,验证前期构建的“运动健听”干预方案在社区患有年龄相关性听力损失老年人中的可行性和有效性,为未来听力康复干预提供一定参考。 |
||||||||||||||||||||||
|
Objectives of Study: |
Through a randomized controlled study, the feasibility and effectiveness of the "Exercise and Listen" intervention program developed earlier were validated among community-dwelling older adults with age-related hearing loss, providing a certain reference for future hearing rehabilitation interventions. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①60周岁≤年龄≤80周岁;②经纯音听力计诊断为双侧对称性感音神经性听力损失,根据WHO听力分级,即较好耳的0.5、1、2、4 kHz 4个频率永久性非助听听阈平均值在20~50dB;③身体活动能力轻度受限或正常:即使用简易运动状况量表测量,得分范围为7分及以上;④知情同意,自愿参与本研究;⑤具备基本的沟通和交流能力。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Age range: 60 years old <= age <= 80 years old; 2.According to the WHO hearing classification, the average value of the permanent non-hearing aid hearing threshold of 0.5, 1, 2 and 4 kHz of the better ear is 20~50dB; 3. Moderate or no limitation of physical activity: measured by the simplified physical activity status scale, the score range is 7 or above; 4. Informed consent and voluntary participation in the study; 5. Have basic communication and exchange ability. |
||||||||||||||||||||||
|
排除标准: |
①因外伤、先天性畸形、梅尼埃病、听神经瘤和自身免疫性疾病等因素造成的听力损失;②既往患有精神病史及意识障碍;③合并有其他任何运动相关禁忌证,包括但不限于:近3个月内心肌梗死或肢体骨折、不稳定型心血管疾病等;④正在参加过其他试验项目;⑤拒绝随机化分配。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Hearing loss caused by external injuries, congenital malformations, Meniere's disease, acoustic neuromas, and autoimmune diseases; 2.A history of mental illness or consciousness disorder in the past; 3.Co-existing with any other exercise-related contraindications, including but not limited to: myocardial infarction or limb fracture within the past 3 months, unstable cardiovascular diseases, etc.; 4.Participating in other trial projects; 5.Refusing randomization allocation. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-12-10 00:00:00至 To 2025-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-12-10 00:00:00 至 To 2025-03-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
使用电子生成的随机化列表(www.randomizer.org)将纳入的受试者按照简单的随机化程序按1:1的比例随机分为干预组和对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Using an electronically generated randomization list (www.randomizer. org), the enrolled subjects were randomly divided into an intervention group and a control group in a 1:1 ratio according to a simple randomization procedure. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
研究很难对病人和干预的实施者施盲,属于“开放标签”研究,但对结局指标的测量者实施盲法:告知研究对象他们被随机纳入一组,但不会告知他们具体属于哪一组。 |
|
Blinding: |
It is difficult to blind patients and intervention implementers in the study, which belongs to an "open label" study. However, blinding the outcome measure measurers: informing the study subjects that they are randomly assigned to one group, but not specifying which group they belong to. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验结束文章发表后可共享原始数据,共享网络平台:http://www.medresman.org.cn/login.aspx |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the experiment is completed and the article is published, the original data can be shared on the following network platform: http://www.medresman.org.cn/login.aspx |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
无 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
None |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |